Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
Go back to Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer| (NASDAQ: LRMR) | Delayed: 2.42 -0.02 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $ | |||
| Open | $2.40 | 52 Week Low | $ | |||
| Day High | $2.54 | P/E | N/A | |||
| Day Low | $2.39 | EPS | $ | |||
| Volume | 1,512,896 | |||||



